BACKGROUND/AIMS: The metabolic syndrome (MeSy) may be related to Alzheimer's disease (AD). Our aims were to investigate the association of the MeSy with incident dementia in a multiethnic elderly cohort in the United States. METHODS: We conducted cross-sectional and prospective analyses in 2,476 men and women aged 65 years and older and with data available on the MeSy and dementia diagnosis in Northern New York City. MeSy was defined by the National Cholesterol Education Program Adult Treatment Program III and the European Group for the Study of Insulin Resistance criteria. Dementia was diagnosed using standard criteria. RESULTS: No association was found between MeSy and prevalent dementia. After 4.4 years of follow-up, 236 individuals of the 1,833 without prevalent dementia developed dementia. MeSy was not associated with incident dementia. Of the components of the MeSy, diabetes and hyperinsulinemia were associated with an increased risk of incident AD [hazard ratio 1.4 (95% CI 1.0-2.1), and hazard ratio 1.4 (95% CI 0.9-2.7), respectively] and dementia associated with stroke [hazard ratio 1.9 (95% CI 1.1-3.1), and hazard ratio 2.3 (95% CI 1.1-4.7), respectively]. CONCLUSIONS: The MeSy was not associated with an increased dementia risk in a multiethnic elderly cohort, but diabetes and hyperinsulinemia were. In the elderly, examining diabetes and hyperinsulinemia separately may be preferable to using the MeSy as a risk factor. 2007 S. Karger AG, Basel
BACKGROUND/AIMS: The metabolic syndrome (MeSy) may be related to Alzheimer's disease (AD). Our aims were to investigate the association of the MeSy with incident dementia in a multiethnic elderly cohort in the United States. METHODS: We conducted cross-sectional and prospective analyses in 2,476 men and women aged 65 years and older and with data available on the MeSy and dementia diagnosis in Northern New York City. MeSy was defined by the National Cholesterol Education Program Adult Treatment Program III and the European Group for the Study of Insulin Resistance criteria. Dementia was diagnosed using standard criteria. RESULTS: No association was found between MeSy and prevalent dementia. After 4.4 years of follow-up, 236 individuals of the 1,833 without prevalent dementia developed dementia. MeSy was not associated with incident dementia. Of the components of the MeSy, diabetes and hyperinsulinemia were associated with an increased risk of incident AD [hazard ratio 1.4 (95% CI 1.0-2.1), and hazard ratio 1.4 (95% CI 0.9-2.7), respectively] and dementia associated with stroke [hazard ratio 1.9 (95% CI 1.1-3.1), and hazard ratio 2.3 (95% CI 1.1-4.7), respectively]. CONCLUSIONS: The MeSy was not associated with an increased dementia risk in a multiethnic elderly cohort, but diabetes and hyperinsulinemia were. In the elderly, examining diabetes and hyperinsulinemia separately may be preferable to using the MeSy as a risk factor. 2007 S. Karger AG, Basel
Authors: M Kivipelto; E L Helkala; M P Laakso; T Hänninen; M Hallikainen; K Alhainen; H Soininen; J Tuomilehto; A Nissinen Journal: BMJ Date: 2001-06-16
Authors: A Ruitenberg; I Skoog; A Ott; O Aevarsson; J C Witteman; B Lernfelt; F van Harskamp; A Hofman; M M Breteler Journal: Dement Geriatr Cogn Disord Date: 2001 Jan-Feb Impact factor: 2.959
Authors: S Kalmijn; D Foley; L White; C M Burchfiel; J D Curb; H Petrovitch; G W Ross; R J Havlik; L J Launer Journal: Arterioscler Thromb Vasc Biol Date: 2000-10 Impact factor: 8.311
Authors: Robert D Abbott; J David Curb; Beatriz L Rodriguez; Kamal H Masaki; Katsuhiko Yano; Irwin J Schatz; G Webster Ross; Helen Petrovitch Journal: Ann Epidemiol Date: 2002-04 Impact factor: 3.797
Authors: Megan M Marron; Iva Miljkovic; Robert M Boudreau; Kaare Christensen; Mary F Feitosa; Joseph H Lee; Paola Sebastiani; Bharat Thyagarajan; Mary K Wojczynski; Joseph M Zmuda; Anne B Newman Journal: Metabolism Date: 2019-01-30 Impact factor: 8.694
Authors: Irving E Vega; Laura Y Cabrera; Cassandra M Wygant; Daniel Velez-Ortiz; Scott E Counts Journal: J Alzheimers Dis Date: 2017 Impact factor: 4.472
Authors: Tasnime N Akbaraly; Mika Kivimaki; Martin J Shipley; Adam G Tabak; Markus Jokela; Marianna Virtanen; Michael G Marmot; Jane E Ferrie; Archana Singh-Manoux Journal: Diabetes Care Date: 2009-10-16 Impact factor: 19.112